FDA Investigator Tracy R Ball

Tracy R Ball has inspections in 6 countries as of 23 Oct 2023. Tracy R Ball has collaborated with a combinined 3326 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
278
Last Inspection Date:
23 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Argentina, Spain, Denmark, Poland, United Kingdom of Great Britain and Northern Ireland
Co-Investigator(s):
A Williams, Aaron P Wozniak, Abdur Rashid, Adam R Cooke, Alaric C Denton, Alphonso A Haupt, III, Amy H Ruble, Andrace Lde Yampert, Andrea Lwilliams Jones, Angelica M Hernandez, Ann B Borromeo, Anna M Brannen, Anthony J Grace, Arthur G Hurst, Barbara A Rusin, Barbara M Frazier, Barbara T Carmichael, Betsy C Galliher, Bonita S Chester, Brandy D Brown, Brentley S Collins, Brett D Weed, Brett Weed, Brian A Graves, Brian R Yaun, Bridegan, Brown, Buford, Burnell M Henry, Cara Fiore, PhD, Cara M Minelli, Carl E Lovrich, Carlos A Ortiz, Carol F Robinson, Cassandra L Abellard, CDR Thomas R Berry, PPh, Cheryl A Grandinetti, Cheryl D Barton, Cheryl Llove Harris, Chestnut, Chris Alexander, Christine M O'leary, Christopher S Keating, Claudette D Brooks, Constance Y Fears, Contractor Bridgers, Cordelia J Brammer, Cynthia F Kleppinger, MD, Daphne Santiago, PhD, David T Glover, David Williams, Dawn M Braswell, Deborah A Greco, Deborah M Trout, Debra J Tucker, Dellarese L Herbert, Derek C Price, Devaughn Edwards, Deyaa Shaheen, Diane Hall, Doretha M Tonkins, Doretha M Wilson, Douglas L Page, Dr. Jason R Caballero, Edecia A Richards, Edward Deberry, Edward Lukeman, Eileen J Bannerman, Eric S Weilage, Ernest H Blackwood, Esra Toussaint, Frank Wackes, Gabriel R Mclemore, Gamal A Norton, Gates E Raynor, George G Calafactor, Gideon N Esuzor, Hai Lien T Phung, Harshal J Desai, Helen R Bester, Hristu B Chepa, Ibad U Khan, Jacqueline Mdiaz Albertini, James P Lewis, Jr, Janet B Gray, Janete F Guardia, Jared P Stevens, Jason F Chancey, Jason K Morgan, Jawaid Hamid, Jeff M Uriarte, Jennifer D Hollstrom, Jessica A Stephens, Jessica D Weber, Jessica Fields, Joanne T Gabay, John E Aghadia, Johnson, Jonathan G Swoboda, Joseph F Owens, Joyce A Rockwell, Kara D Dobbin, Kassa Ayalew, MD, Katelynn J Rollins, Kathleen D Culver, Kemejumaka N Opara, Kenneth L Smalls, Khalid M Khan, Kimberly Cdelk Brooks, Kip J Hanks, Lareese K Thomas, Larry K Hampton, Lauryl A Smith, Lawrence, Leon L Crawley, Leslie W Gilbert, Lewis K Antwi, Lillie D Witcher, Lisa P Oakes, Lorenzo Jones, LT Daveta L Bailey, LT Tamara J Henderson, Mancia R Walker, Marie F Morin, Marla A Cassidy, Mary Alice Papdimitriou, Mary T Carden, Megan T Ziegler, Metitia G Sanders, Metitia M Gramby, Miaja Umaedi, Michelle D Haamid, Michelle L Jones, Morrell, Nancy E Fontaine, Nicholas M Smith, Nicole K Trudel, Nicole M Bell, Nigel L Hirth, Noreen Muniz, Omotunde O Osunsanmi, Pamela L Vega, Panney H Mccarver, Paul W Moy, Paula J Bretz, Penny H Mccarver, Rachael A Moliver, Rachael L Cook, Rachel M Skeete, Randy D Baxter, Randy L Clarida, Rashard A Knight, Rashonda N Rucker, Reba A Gates, Rebecca Rodriguez, Regan T Harp, Richard J Bashay, Richard L Garcia, Robert C Coleman, Robert L Lewis, Jr, Robin N Goins, Rosia E Nesbitt, Samantha J Bradley, Sarah L Holliday, Scott E Norris, Seneca D Toms, Sereen Gmorgan Murray, Sharna D Pratt, Sherri J Jackson, Simone E Pitts, Smith, Sonya M Edmonds, State Agency, Susan M Jackson, Susan O Oladeji, Tajah L Blackburn, Tallman, Tamara M Casselman, Thomas D Clarida, Thomas W Nojek, Tracy K Bell, Tracy L Ramirez, Tracy L Ramseur, Trang N Cox, Tyrico K English, Vanessa E Coulter, Veronica Fuentes, MS, Vicky C Stoakes, Viviana Matta, Watson, William P Tonkins, Williams, Xiomara Copeland, Yiyue Zhang (nmi), PhD, Youmin Wang

Tracy R Ball's Documents

Publish Date Document Type Title
August, 2004 FDA 483 SC Johnson Professional USA, Inc. - Form 483, 2004-08-18
August, 2002 EIR Crain, Jack L., M.D. - Clinical Investigator - EIR, 2002-08-14
October, 2003 EIR McKesson Corporation - EIR, 2003-10-08
September, 2003 FDA 483 The Ritedose Corporation - Form 483, 2003-09-12
March, 2002 FDA 483 Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483, 2002-03-22
July, 2001 EIR Frenette, Gary MD - EIR, 2001-07-27
November, 2001 EIR Generics Bidco II LLC d/b/a Prinston Laboratories - EIR, 2001-11-09
June, 2000 EIR Leiner Health Product, Llc - EIR, 2000-06-01
January, 2000 EIR Generics Bidco II LLC d/b/a Prinston Laboratories - EIR, 2000-01-14
December, 2003 EIR Ei, LLC - EIR, 2003-12-23
April, 2004 FDA 483 Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483, 2004-04-02
February, 2000 EIR Marc T. Silver, MD - EIR, 2000-02-01
November, 2000 FDA 483 Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483, 2000-11-21
December, 2003 FDA 483 Response Ei, LLC - Form 483R, 2004-01-20
August, 2000 EIR Rotberg, Michael - EIR, 2000-08-03
July, 2011 EIR SpecGx LLC - EIR, 2011-07-21
July, 2009 FDA 483 Terry Arnold, M.D. - Form 483, 2009-07-22
October, 2002 EIR GlaxoSmithKline LLC - EIR, 2002-10-17
April, 2012 FDA 483 Marlin Company, Inc. - Form 483, 2012-04-18
November, 2015 FDA 483 Duke Clinical Research Institute - Form 483, 2015-11-04
February, 2006 FDA 483 Marlin Company, Inc. - Form 483, 2006-02-02
January, 2012 EIR Chelsea Therapeutics Inc - EIR, 2012-01-19
June, 2002 EIR Ei, LLC - EIR, 2002-06-14
June, 2000 FDA 483 Heyder, Albrecht - Form 483, 2000-06-10
February, 2002 EIR Albemarle Corporation - EIR, 2002-02-14
June, 2000 EIR Heyder, Albrecht - EIR, 2000-06-09
September, 2001 EIR Walter D. Holder, MD Clinical Investigator - EIR, 2001-09-06
February, 2001 FDA 483 Leiner Health Product, Llc - Form 483, 2001-02-01
September, 2001 FDA 483 Walter D. Holder, MD Clinical Investigator - Form 483, 2001-09-06
December, 2003 FDA 483 Ei, LLC - Form 483, 2003-12-23
February, 2018 EIR GW RESEARCH LTD - EIR, 2018-02-02
February, 2002 EIR Casat, Charles D., MD - Clinical Investigator - EIR, 2002-02-26
March, 2007 FDA 483 Response Leiner Health Product, Llc - Form 483R, 2007-04-09
January, 2000 FDA 483 Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483, 2000-01-14
September, 2009 FDA 483 CSL Plasma, Inc - Form 483, 2009-09-18
July, 2003 FDA 483 Carolina Medical Inc - Form 483, 2003-07-18
September, 2013 FDA 483 SC Johnson Professional USA, Inc. - Form 483, 2013-09-24
March, 2002 EIR Generics Bidco II LLC d/b/a Prinston Laboratories - EIR, 2002-03-22
January, 2005 EIR Ei, LLC - EIR, 2005-01-14
November, 2000 EIR Generics Bidco II LLC d/b/a Prinston Laboratories - EIR, 2000-11-21
March, 2007 FDA 483 Leiner Health Product, Llc - Form 483, 2007-03-16
October, 2000 FDA 483 American National Red Cross (The) Carolinas Region - Form 483, 2000-07-26
December, 2002 EIR Generics Bidco II LLC d/b/a Prinston Laboratories - EIR, 2002-12-12
April, 2004 FDA 483 Response Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483R, 2004-04-29
November, 2000 FDA 483 Response Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483R, 2000-11-28
May, 2002 FDA 483 Frenette, Gary MD - Form 483, 2002-05-28
October, 2015 EIR Patheon Softgels Inc. - EIR, 2015-10-05
April, 2017 EIR BioAgilytix Labs - EIR, 2017-04-26
February, 2001 EIR Leiner Health Product, Llc - EIR, 2001-02-01
June, 2016 EIR Mohammed Alhatou - EIR, 2016-06-16
September, 2013 EIR SC Johnson Professional USA, Inc. - EIR, 2013-09-24
September, 2012 EIR Akesis, LLC - EIR, 2012-09-14
November, 2001 FDA 483 Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483, 2001-11-09
December, 2012 EIR Custom Analytics LLC - EIR, 2012-12-11
February, 2002 FDA 483 Dr. Charles D. Casat - Clinical Investigator - Form 483, 2002-02-26
July, 2001 EIR McKesson Corporation - EIR, 2001-07-02

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more